PARABDRUGS

PARABDRUGS · NSE · inactive

5.50

-0.25 (-4.35%)

as of 25 Jan 2021 close

Open

5.50

High

5.50

Low

5.50

Prev close

5.75

52w high

6.65

08 Jan 2021

52w low

0.65

17 Mar 2020

VWAP

5.50

Delivery %

—

n/a

Volume 123 · turnover ₹1,000 · NSE bhavcopy (official close) · history since 01 Jul 2010

Series: BE
F&O: No
Status: Inactive since 02 Apr 2019

Source: NSE equity master · as of 01 Apr 2019

Daily · NSE EOD

Exchange announcements

Source: NSE corporate filings · latest Today 12:06 IST

All M&A AGM / meeting Analyst meet Board meeting Business update Management Compliance Corporate action Credit rating Dividend Exchange query General update Insider / SAST Legal Order win Results

22 Jan 2021 17:01
Compliance
Parabolic Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
PDF · -
30 Dec 2020 14:38
Compliance
Parabolic Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
PDF · -
14 Dec 2020 14:54
Compliance
Parabolic Drugs Limited has informed the Exchange about related Party Transactions
PDF · -
22 Oct 2020 16:13
Compliance
Parabolic Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
PDF · -
25 Sept 2020 18:21
Compliance
Parabolic Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
PDF · -
24 Jul 2020 14:47
Compliance
Parabolic Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
PDF · -
13 Jul 2020 12:38
Compliance
Parabolic Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
PDF · -
21 Jul 2018 15:27
Compliance
Parabolic Drugs Limited has informed the Exchange regarding change in Corporate Office of the company from S.C.O. 99-100, level third and fourth, Sector 17-B, Chandigarh to S.C.O. 186-187, 2nd floor, Sector 8C, Chandigarh.
PDF · -
21 Jul 2018 15:21
Compliance
Parabolic Drugs Limited has informed the Exchange regarding change in Registered Office of the company.from S.C.O. 99-100, level third and fourth, Sector 17-B, Chandigarh to S.C.O. 186-187, 2nd floor, Sector 8C, Chandigarh.
PDF · -
18 Feb 2013 17:36
Compliance
Parabolic Drugs Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 13, 2013, has decided to shift its corporate office from its existing situation at 9 A.B., Taimoor Nagar, New Friends Colony, New Delhi To S.C.O. 99-100, Third Floor, Sector 17 B, Chandigarh.

Coming next in news

Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.

Results & board-meeting calendar
Dividend, split, AGM calendar
Headlines with source and timestamp
Two-line factual filing summaries